Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Hegenbart

Showing results (111-120 of 237) with videos related to

Pageof 24
Sort By:
Haematologica|October 22, 2013
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapySascha Dietrich, Jürgen G Okun, Kathrin Schmidt, et al.
Brain : a Journal of Neurology|December 21, 2014
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurographyJennifer Kollmer, Ernst Hund, Benjamin Hornung, et al.
British Journal of Haematology|August 25, 2021
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantationElias K Mai, Thomas Schmitt, Aleksandar Radujkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimensTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Cytometry. Part B, Clinical Cytometry|December 16, 2015
Potential therapeutic targets in plasma cell disorders: A flow cytometry studyKatharina Lisenko, Stefan Schönland, Ute Hegenbart, et al.
ESC Heart Failure|December 14, 2022
Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosisIsabel A Hoerbrand, Martin J Volz, Fabian Aus dem Siepen, et al.
Clinical Kidney Journal|June 24, 2026
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significanceBen Sprangers, Camille Cohen, Viviane Gnemmi, et al.
Nature Communications|June 15, 2024
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosisSara Karimi-Farsijani, Peter Benedikt Pfeiffer, Sambhasan Banerjee, et al.
Nature Communications|November 7, 2024
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosisSara Karimi-Farsijani, Kartikay Sharma, Marijana Ugrina, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Pageof 24

Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
Haematologica|October 22, 2013
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapySascha Dietrich, Jürgen G Okun, Kathrin Schmidt, et al.
Brain : a Journal of Neurology|December 21, 2014
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurographyJennifer Kollmer, Ernst Hund, Benjamin Hornung, et al.
British Journal of Haematology|August 25, 2021
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantationElias K Mai, Thomas Schmitt, Aleksandar Radujkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimensTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Cytometry. Part B, Clinical Cytometry|December 16, 2015
Potential therapeutic targets in plasma cell disorders: A flow cytometry studyKatharina Lisenko, Stefan Schönland, Ute Hegenbart, et al.
ESC Heart Failure|December 14, 2022
Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosisIsabel A Hoerbrand, Martin J Volz, Fabian Aus dem Siepen, et al.
Clinical Kidney Journal|June 24, 2026
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significanceBen Sprangers, Camille Cohen, Viviane Gnemmi, et al.
Nature Communications|June 15, 2024
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosisSara Karimi-Farsijani, Peter Benedikt Pfeiffer, Sambhasan Banerjee, et al.
Nature Communications|November 7, 2024
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosisSara Karimi-Farsijani, Kartikay Sharma, Marijana Ugrina, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Pageof 24